"We will pump you up!"
Many have attributed aggressive risk taking as one of the causes of the financial crisis, but Wall Streeters are now turning towards testosterone therapy in hopes of gaining back that edge amid a competitive and speculative job environment within the financial industry.
The Financial Times is out with a fascinating article on how testosterone therapy businesses in New York are surging because of Wall Streeters eager to use the the hormone to meet the demands of their jobs and come out on top in an industry where job opportunities are slowly shrinking.
The business of testosterone therapy has taken off so rapidly that Cenegenetics, a male hormone therapy company, will be opening up a New York office near the NYSE next month. The growth of Cenegenetics since the financial crisis reflects the popularity of testosterone therapy: revenue at the company last year was $60 million, nearly double from $37 million in 2007.
Read more: http://www.businessinsider.com/shocker-wall-streeters-are-juicing-to-be-better-at-their-jobs-2012-2#ixzz1lvmjl7RC
No comments:
Post a Comment